ADCY9 antibody
Quick Overview for ADCY9 antibody (ABIN1944823)
Target
See all ADCY9 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Isotype
- IgG1
-
-
-
-
Application Notes
- WB: 1:1000. IHC: 1:50-1:100
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
-
Storage
- 4 °C,-20 °C
-
-
-
: "Molecular properties and pharmacogenetics of a polymorphism of adenylyl cyclase type 9 in asthma: interaction between beta-agonist and corticosteroid pathways." in: Human molecular genetics, Vol. 14, Issue 12, pp. 1671-7, (2005) (PubMed).
: "An Ile to Met polymorphism in the catalytic domain of adenylyl cyclase type 9 confers reduced beta2-adrenergic receptor stimulation." in: Pharmacogenetics, Vol. 13, Issue 9, pp. 535-41, (2003) (PubMed).
: "Cloning, chromosomal mapping, and regulatory properties of the human type 9 adenylyl cyclase (ADCY9)." in: Genomics, Vol. 50, Issue 1, pp. 97-104, (1999) (PubMed).
-
-
- ADCY9 (Adenylate Cyclase 9 (ADCY9))
-
Alternative Name
- ADCY9
-
Background
- May play a fundamental role in situations where fine interplay between intracellular calcium and cAMP determines the cellular function. May be a physiologically relevant docking site for calcineurin (By similarity).
-
Molecular Weight
- 150701 Da
-
Gene ID
- 115
-
UniProt
- O60503
-
Pathways
- EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Thyroid Hormone Synthesis, cAMP Metabolic Process, Myometrial Relaxation and Contraction, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma
Target
-